U.S. Patient Survival Outcomes Report

The U.S. Patient Survival Outcomes Report displays an estimate of patients who are alive after a bone marrow or cord blood transplant. The estimates are shown:

By disease and length of time after transplant: 100 days, 1 year, and 3 years
By the type of donor who provided the cells for transplant:
- Autologous (the patient's cells)
- Related allogeneic (a patient's sibling or another family member's cells)
- Unrelated allogeneic (a volunteer donor's cells)

The cells used for transplant can be from bone marrow, peripheral blood or umbilical cord blood after a baby is born.

Choose the information for your report and then click Continue.
(To change a selection, use Previous Step.)

Step 1: Select a Disease

Last Updated: August 31, 2007

Reading This Report

Glossary for U.S. Transplant Data includes explanations of words and phrases used for this report.
Data in these reports are from January 1, 2000 through December 31, 2005.
U.S. transplant centers provided these data voluntarily to the National Marrow Donor Program^® (NMDP) and the Center for International Blood and Marrow Transplant Research^® (CIBMTR). (More transplants to treat a disease may have been performed, but the data were not reported to the CIBMTR or the NMDP.)

Trends and More Data

View slides of transplant and outcomes data collected by the Center for International Blood and Marrow Transplant Research (CIBMTR) and information about transplants using only unrelated donors collected by the National Marrow Donor Program (NMDP).

Outcomes Data (CIBMTR and NMDP) (not a U.S. Government Web site)
Summary Slides (CIBMTR) (not a U.S. Government Web site)

This is an official U.S. Government Web site managed by the
Health Resources and Services Administration, U.S. Department of Health & Human Services.